Volta Labs Enhances Sequencing with Callisto Automation System
Volta Labs Expands Partnership with PacBio for Sequencing Automation
In a significant move, Volta Labs™, a pioneering genomics applications company, has announced its participation in the PacBio Compatible program. This initiative aims to elevate the capabilities of laboratories committed to Next-Generation Sequencing (NGS) by integrating automation into their workflows.
Automated Solutions for Enhanced Sequencing
By joining the PacBio Compatible program, Volta Labs is stepping up its commitment to enhancing library preparation processes. The centerpiece of this effort is the Callisto™ Sample Prep System. This innovative platform allows labs to maximize efficiency, enabling them to perform high-quality PacBio HiFi library preparation with significantly reduced hands-on time.
Streamlined Processes with Callisto Technology
With the Callisto Sample Prep System, labs can prepare libraries in less than 30 minutes of direct involvement and leave the system to handle the next steps for approximately 5.5 hours. This automation is particularly crucial for labs seeking to optimize their throughput and accuracy in library prep.
Importance of Efficiency in Sequencing
As various organizations face challenges related to resource constraints, Volta Labs aims to alleviate these issues through innovative technology. The streamlined library preparation process allows labs to redirect their attention from manual tasks to actual sequencing and data analysis, an area where they can derive more significant scientific value.
Industry Response and Future Vision
David Miller, VP of Global Marketing at PacBio, expressed enthusiasm regarding the partnership. He highlighted the transformative potential of the Callisto platform in reducing both setup and operational times, which promotes a more productive laboratory environment. This partnership aligns with PacBio’s vision of making high-quality sequencing more accessible to a broader range of users.
Collaborative Efforts in Advancing Genomics
The collaboration is a landmark moment for Volta Labs as they have been tirelessly working alongside the PacBio team to enhance library prep systems. Greg Young, senior product manager at PacBio, recently spotlighted the value brought by Volta's automation during a webinar, emphasizing the scalability it offers to laboratories engaging in PacBio sequencing. Callisto's flexibility accommodates batch sizes, allowing various configurations of reactions based on lab needs.
Understanding Volta Labs and Its Mission
Volta Labs is at the forefront of transforming genomic methodologies. Their innovative digital fluidics platform aims to elevate the consistency and efficiency of sample preparation. By environmentally transforming research in biology, Volta assists researchers in focusing on pressing scientific questions, driving innovation and discovery.
Why Choose Callisto for Library Prep?
With Callisto, even users with limited experience can generate high-quality PacBio libraries swiftly and effectively, mitigating errors and variability among different operators. This user-friendly dynamic makes Callisto a valuable asset for any lab, regardless of its scale or experience level in genomic research.
Conclusion and Future Outlook
The integration of Volta Labs' technology within the PacBio Compatible program marks a promising future for genomic sequencing workflows. As labs increasingly leverage automation, the landscape of genomic research continues to evolve, offering unprecedented opportunities for discovery and innovation.
Frequently Asked Questions
What is the purpose of the PacBio Compatible program?
The PacBio Compatible program aims to enhance laboratory efficiency by integrating compatible technologies and solutions into existing workflows to support Pacific Biosciences’ sequencing solutions.
How does the Callisto Sample Prep System work?
The Callisto Sample Prep System automates the sample preparation process, allowing labs to prepare high-quality libraries with minimal hands-on time and maximum operational efficiency.
Who would benefit from using the Callisto system?
Laboratories, regardless of their size or expertise in sequencing, can benefit from the Callisto system by streamlining their library preparation, thereby enhancing throughput and accuracy.
What are the advantages of automated library prep?
Automated library prep reduces human error, minimizes hands-on time, and allows researchers to focus on sequencing rather than manual preparation, which leads to increased efficiency and reproducibility.
What is the mission of Volta Labs?
Volta Labs strives to transform how biological research and analyses are conducted by providing innovative technologies that maximize performance, consistency, and scalability in sample preparation.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
